REFRACTORY CLL

Clinical trials for REFRACTORY CLL explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY CLL trials appear

Sign up with your email to follow new studies for REFRACTORY CLL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New weapon tested against Tough-to-Treat blood cancer

Disease control Recruiting now

This early-stage study is testing a new type of CAR-T cell therapy called LMY-920 for adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has returned or stopped responding to standard treatments. The therapy uses the patient's own modified imm…

Matched conditions: REFRACTORY CLL

Phase: PHASE1 • Sponsor: Paolo Caimi, MD • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

REFRACTORY CLL

Get alerted when new REFRACTORY CLL trials appear

New weapon tested against Tough-to-Treat blood cancer